Compositions and methods for identifying antigens which elicit an immune response
CA 2374237 A1 · Owner: Wake Forest University · Inventors: Chen, Si-Yi; You, Zhaoyang
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention relates to an expression vector wherein said expression vector comprises a polynucleotide promoter sequence a polynucleotide encoding a , signal sequence a polynucleotide encoding an antigen protein or peptide a , polynucleotide encoding a cell binding element and a polynucleotide , polyadenylation sequence all operatively linked. More particularly it relates , to the method of eliciting an immune response directed against an antigen in a mammal comprising the steps of introducing the expression vector into a cell expressing the vector to produce an antigen under conditions wherein the antigen is secreted from the cell, endocytosing the secreted antigen into the cell, …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 5, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 5, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 5, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.